Anti-tumor therapies comprising a combination of a cartilage extract and an anti-neoplastic agent providing high efficacy and low toxic side effects
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 15, 2005
Issued Date -
N/A
app pub date -
Feb 28, 2002
filing date -
Mar 11, 1997
priority date (Note) -
Expired
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Patent Longevity
|
Forward Citations
|
Abstract
This invention described a novel use for cartilage extract, namely a shark cartilage extract, in a combined anti-tumor therapy. The cartilage extract is used in combination with anti-neoplastics. The combined therapy provides for a higher anti-tumor efficacy with no concomitant increase, even better with a decrease, of toxic side effects.
First Claim
all claims..Other Claims data not available
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
AETERNA ZENTARIS INC | 1405 DU PARC TECHNOLOGIQUE BLVD QUEBEC QUEBEC G1P 4P5 |
International Classification(s)

- 2002 Application Filing Year
- A61K Class
- 10774 Applications Filed
- 3504 Patents Issued To-Date
- 32.53 % Issued To-Date
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Dupont, Eric | Saint-Nicolas, CA | 19 | 166 |
# of filed Patents : 19 Total Citations : 166 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 0 Citation Count
- A61K Class
- 0 % this patent is cited more than
- 20 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events
Date | Code | Event | Description |
---|---|---|---|
Jun 23, 2021 | MAFP | MAINTENANCE FEE PAYMENT | free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY year of fee payment: 4 |
Jan 16, 2018 | I | Issuance | |
Dec 27, 2017 | STCF | INFORMATION ON STATUS: PATENT GRANT | free format text: PATENTED CASE |
Nov 27, 2014 | P | Published | |
Oct 14, 2014 | AS | ASSIGNMENT | free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MICROSOFT CORPORATION;REEL/FRAME:034747/0417 Owner name: MICROSOFT TECHNOLOGY LICENSING, LLC, WASHINGTON Effective Date: Oct 14, 2014 free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MICROSOFT CORPORATION;REEL/FRAME:039025/0454 Owner name: MICROSOFT TECHNOLOGY LICENSING, LLC, WASHINGTON Effective Date: Oct 14, 2014 |
Aug 11, 2014 | F | Filing | |
Aug 11, 2014 | AS | ASSIGNMENT | free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:YANDEK, MATTHEW R.;BRAR, GURASHISH SINGH;LI, HUI;SIGNING DATES FROM 20111209 TO 20111214;REEL/FRAME:033507/0090 Owner name: MICROSOFT CORPORATION, WASHINGTON |
Dec 15, 2011 | PD | Priority Date |

Matter Detail

Renewals Detail
